Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05514847 · ClinicalTrials.gov registry record · Phase 4
Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients
A Phase 4 study of Pregnancy Related and Preeclampsia, sponsored by University of Virginia.
- Active
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT05514847: Active Phase 4 study of Pregnancy Related and Preeclampsia, sponsored by University of Virginia.
NCT05514847 is a Phase 4 study of Pregnancy Related and Preeclampsia that is active but no longer recruiting, run by University of Virginia. The registered enrollment target is 150 participants, below the 1,961-participant average among 99 other Pregnancy Related trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05514847, a Phase 4 study of Pregnancy Related and Preeclampsia, is active but no longer recruiting, sponsored by University of Virginia.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
This will be a randomized, open-label, controlled trial of patients at high risk of developing preeclampsia examining 81 mg/day vs 162mg/day daily acetylsalicylic acid (ASA) use. Based on screening results, patients will be randomized as outlined below into one of four groups. The proposed study is a pilot to determine if the higher dose of ASA has positive impacts on measures that predict preeclampsia, compared to the lower dose. If positive findings, data from this study could be used to develop a larger trial powered to determine if the higher ASA dose can improve clinical outcomes.
Primary Outcome
To assess the effect of 81mg/day vs 162mg/day on the progression of PAPP-A in pregnancy. Unit of measure is multiples of the median (MoM).
Conditions Studied
Interventions
- DRUG Aspirin 81Mg Ec Tab
- DRUG Aspirin 162Mg Ec Tab
Study Locations (1)
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2025-12-31 |
| Phase | Phase 4 |
What the registry record for NCT05514847 still lists
NCT05514847 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,961-participant average among 99 other Pregnancy Related trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Pregnancy Related appearing as the primary indexed condition, and to 2 interventions - of which Aspirin 81Mg Ec Tab is the first listed.
NCT05514847 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05514847 about?
NCT05514847 is a clinical study titled "Low Dose Aspirin for Preterm Preeclampsia Preventionmg/day Dose in High-risk Patients". This will be a randomized, open-label, controlled trial of patients at high risk of developing preeclampsia examining 81 mg/day vs 162mg/day daily acetylsalicylic acid (ASA) use. Based on screening results, patients will be randomized as outlined below into one of four groups. The proposed study is ...
What is the current status of trial NCT05514847?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2022-10-01. Estimated completion is 2025-12-31.
What conditions does trial NCT05514847 study?
This clinical trial studies the following conditions: Pregnancy Related, Preeclampsia.
What interventions are being tested in trial NCT05514847?
The interventions under investigation include: Aspirin 81Mg Ec Tab (DRUG), Aspirin 162Mg Ec Tab (DRUG).
Who is sponsoring clinical trial NCT05514847?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05514847 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Related
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05514847's enrollment target sits among peer trials
150 48th of 99 higher than 50 of 99 other Pregnancy Related trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy Related trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Antenatal Support for Iron Deficiency Anemia
RECRUITING · Phase 4
-
Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
RECRUITING · Phase 4
-
Perineal Massage Using A Pelvic Wand During Pregnancy
RECRUITING · Phase 4
-
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
ACTIVE NOT RECRUITING · Phase 4
-
Misoprostol Dosing in BMI Greater Than 30
COMPLETED · Phase 4
-
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI